Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0275 Transporter Info
Gene Name	SLC30A6
Transporter Name	Zinc transporter 6
Gene ID	55676
UniProt ID	Q6NXT4

Post-Translational Modification of This DT
Overview of SLC30A6 Modification Sites with Functional and Structural Information
Sequence	M G T I H L F R K P Q R S F F G K L L R E F R L V A A D R R S W K I L L F G V I N L I C T G F L L M W C S S T N S I A L T A Y T Y L T I F D L F S L M T C L I S Y W V T L R K P S P V Y S F G F E R L E V L A V F A S T V L A Q L G A L F I L K E S A E R F L E Q P E I H T G R L L V G T F V A L C F N L F T M L S I R N K P F A Y V S E A A S T S W L Q E H V A D L S R S L C G I I P G L S S I F L P R M N P F V L I D L A G A F A L C I T Y M L I E I N N Y F A V D T A S A I A I A L M T F G T M Y P M S V Y S G K V L L Q T T P P H V I G Q L D K L I R E V S T L D G V L E V R N E H F W T L G F G S L A G S V H V R I R R D A N E Q M V L A H V T N R L Y T L V S T L T V Q I F K D D W I R P A L L S G P V A A N V L N F S D H H V I P M P L L K G T D D L N P V T S T P A K P S S P P P E F S F N T P G K N V N P V I L L N T Q T R P Y G F G L N H G H T P Y S S M L N Q G L G V P G I G A T Q G L R T G F T N I P S R Y G T N N R I G Q P R P
PTM type	X-Methylation X-Phosphorylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Methylation
Arginine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A6			[1]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	440
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC30A6 Arginine 440 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A6			[2]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	449
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC30A6 Arginine 449 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A6			[3]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	455
Experimental Method	Co-Immunoprecipitation
Detailed Description	Methylation at SLC30A6 Arginine 455 has the potential to affect its expression or activity.
Phosphorylation
Serine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A6			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	375
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Serine 375 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A6			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	381
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Serine 381 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A6			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Serine 382 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A6			[5] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	388
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Serine 388 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A6			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	421
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Serine 421 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC30A6			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	422
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Serine 422 has the potential to affect its expression or activity.
Threonine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A6			[12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	76
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Threonine 76 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A6			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	84
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Threonine 84 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A6			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	367
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Threonine 367 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC30A6			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	374
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Threonine 374 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC30A6			[5] , [8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	376
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Threonine 376 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC30A6			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	391
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Threonine 391 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC30A6			[16]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	444
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Threonine 444 has the potential to affect its expression or activity.
Tyrosine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A6			[12]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	81
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC30A6 Tyrosine 81 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A6			[17]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	184
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC30A6 Cystine 184 has the potential to affect its expression or activity.
Ubiquitination
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC30A6			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	17
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A6 Lysine 17 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC30A6			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	268
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A6 Lysine 268 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC30A6			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	379
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC30A6 Lysine 379 has the potential to affect its expression or activity.

References
1	Comparing Apples With Apples: The Importance of Clean Data. NASN Sch Nurse. 2019 Mar;34(2):107-108.
2	Inactivity induces resistance to the metabolic benefits following acute exercise. J Appl Physiol (1985). 2019 Apr 1;126(4):1088-1094.
3	Lymphedema after Breast Cancer Treatment. N Engl J Med. 2019 Feb 14;380(7):694.
4	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
5	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
6	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
7	Global Ion Suppression Limits the Potential of Mass Spectrometry Based Phosphoproteomics. J Proteome Res. 2019 Jan 4;18(1):493-507.
8	Modulation of Cl- signaling and ion transport by recruitment of kinases and phosphatases mediated by the regulatory protein IRBIT. Sci Signal. 2018 Oct 30;11(554):eaat5018.
9	Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer. PLoS One. 2018 Oct 2;13(10):e0204658.
10	A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10762-7.
11	Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell. 2008 Aug 8;31(3):438-48.
12	Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H. Int J Mol Sci. 2015 Feb 16;16(2):4209-25.
13	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
14	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
15	Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
16	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
17	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
18	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
19	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence